HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroshi Kiuchi Selected Research

Lower Urinary Tract Symptoms

2/2015Improvement of nocturia and sleep disturbance by silodosin in male patients with lower urinary tract symptoms.
1/2015Histologic evaluation of human benign prostatic hyperplasia treated by dutasteride: a study by xenograft model with improved severe combined immunodeficient mice.
11/2011Survey of overactive bladder symptoms influencing bother before and after treatment with tamsulosin hydrochloride in Japanese patients with benign prostatic hyperplasia.
10/2008Early efficacy of silodosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroshi Kiuchi Research Topics

Disease

12Neoplasms (Cancer)
07/2022 - 12/2006
7Neoplasm Metastasis (Metastasis)
03/2023 - 04/2014
6Renal Cell Carcinoma (Grawitz Tumor)
05/2021 - 04/2002
5Prostatic Neoplasms (Prostate Cancer)
09/2022 - 11/2016
4Carcinoma (Carcinomatosis)
03/2023 - 02/2012
4Lower Urinary Tract Symptoms
02/2015 - 10/2008
4Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2015 - 10/2008
3Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
03/2023 - 04/2014
3Nocturia
01/2023 - 02/2015
3Testicular Neoplasms (Testicular Cancer)
12/2022 - 08/2011
3Cystitis
12/2020 - 05/2009
3Hypogonadism (Hypergonadotropic Hypogonadism)
01/2020 - 08/2014
3Angiomyolipoma
11/2019 - 04/2002
3Overactive Urinary Bladder (Overactive Bladder)
11/2018 - 11/2009
2Pheochromocytoma
11/2021 - 08/2021
2Anorexia
01/2021 - 09/2020
2Kidney Neoplasms (Kidney Cancer)
01/2021 - 10/2016
2Adenoma (Adenomas)
03/2020 - 10/2005
2Tuberous Sclerosis (Bourneville's Disease)
11/2019 - 02/2018
2Inflammation (Inflammations)
01/2015 - 05/2009
2Adenocarcinoma
08/2014 - 02/2006
2Fistula
12/2013 - 02/2012
2Interstitial Cystitis (Interstitial Cystitis, Chronic)
02/2012 - 09/2009
2Pain (Aches)
02/2012 - 09/2009
2Seminoma
08/2011 - 10/2009
1Pelvic Organ Prolapse
01/2024
1Leiomyosarcoma
04/2023
1Hemangiosarcoma (Angiosarcoma)
03/2023
1Neutropenia
12/2022
1Lymphatic Metastasis
09/2022
1Wounds and Injuries (Trauma)
03/2022
1Patent Ductus Arteriosus
03/2022
1Vomiting
11/2021
1Paraganglioma (Paragangliomas)
11/2021
1Multiple Endocrine Neoplasia Type 2a (MEN 2)
11/2021
1Myocarditis (Carditis)
11/2021
1Thyroid Neoplasms (Thyroid Cancer)
08/2021
1Breast Neoplasms (Breast Cancer)
07/2021
1Interstitial Nephritis (Tubulointerstitial Nephritis)
01/2021
1Polyuria
01/2021
1Liver Diseases (Liver Disease)
11/2020
1Diarrhea
09/2020
1Nausea
09/2020
1Lung Neoplasms (Lung Cancer)
03/2020
1Cryptorchidism (Undescended Testes)
01/2020

Drug/Important Bio-Agent (IBA)

7Testosterone (Sustanon)FDA Link
11/2020 - 05/2005
3AndrogensIBA
11/2020 - 08/2011
2Etoposide (VP 16)FDA LinkGeneric
12/2022 - 04/2014
23-Iodobenzylguanidine (Iobenguane)IBA
11/2021 - 08/2021
2Tumor Biomarkers (Tumor Markers)IBA
08/2021 - 04/2014
2LipopolysaccharidesIBA
12/2020 - 07/2014
2Adenosine Triphosphate (ATP)IBA
12/2020 - 11/2018
2trans-sodium crocetinate (crocetin)IBA
11/2019 - 02/2018
2silodosinFDA Link
02/2015 - 10/2008
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
02/2012 - 05/2009
1Polytetrafluoroethylene (Teflon)FDA Link
01/2024
1Polypropylenes (Polypropylene)IBA
01/2024
1Docetaxel (Taxotere)FDA Link
03/2023
1GemcitabineFDA Link
03/2023
1Cisplatin (Platino)FDA LinkGeneric
12/2022
1GelatinIBA
03/2022
1Capsules (Microcapsules)IBA
01/2022
1Anti-Bacterial Agents (Antibiotics)IBA
12/2021
1Succinate Dehydrogenase (Fumarate Reductase)IBA
11/2021
1MetanephrineIBA
11/2021
1Codon (Codons)IBA
11/2021
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
08/2021
1Carboplatin (JM8)FDA LinkGeneric
07/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Imatinib Mesylate (Gleevec)FDA Link
01/2021
1NivolumabIBA
01/2021
1IpilimumabIBA
01/2021
1Phenobarbital (Luminal)FDA Link
12/2020
1Toll-Like Receptor 4IBA
12/2020
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
11/2020
1Flutamide (Eulexin)FDA LinkGeneric
11/2020
1Androgen Antagonists (Antiandrogens)IBA
11/2020
1bicalutamide (Casodex)FDA LinkGeneric
11/2020
1CTLA-4 AntigenIBA
09/2020
1Prednisolone (Predate)FDA LinkGeneric
09/2020
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
03/2020
1Luteinizing Hormone (Lutropin)FDA LinkGeneric
01/2020

Therapy/Procedure

13Therapeutics
12/2022 - 12/2006
9Nephrectomy
03/2023 - 04/2002
8Drug Therapy (Chemotherapy)
04/2023 - 12/2006
6Adrenalectomy
07/2022 - 10/2005
4Radiotherapy
03/2023 - 12/2006
3Transplantation
10/2016 - 12/2006
2Aftercare (After-Treatment)
03/2023 - 11/2011
2Bathroom Equipment
01/2023 - 01/2022
2Lymph Node Excision (Lymph Node Dissection)
12/2022 - 09/2022
2Castration
09/2022 - 01/2017
2Urinary Catheters
03/2022 - 02/2006
2Cryosurgery
05/2021 - 10/2016
2Prostatectomy (Retropubic Prostatectomy)
08/2014 - 02/2006
2Orchiectomy (Orchidectomy)
08/2011 - 10/2009
1Curettage
03/2023
1Induction Chemotherapy
12/2022
1Combined Modality Therapy
12/2022
1Critical Care (Surgical Intensive Care)
11/2021